Journal Guide

Cancer Biotherapy and Radiopharmaceuticals is a peer-reviewed journal covering cutting-edge biotherapy and innovative investigations of methods to improve cancer therapy. Includes more selective delivery of drugs, biologicals, radiopharmaceuticals, and other agents, and advances in delivery instrumentation and technology, with the aim of increasing efficacy of therapy, decreasing toxicity, and/or improving convenience of therapy.Topics include:• Pre-targeted cancer therapy• Clinical trials in cancer research• Antibody therapy and imaging• Tumor cell vaccines• Radioimmunotherapy• T-cell therapy• Molecular targeted therapy and imaging• Drug resistance.

Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.

Cancer Nanotechnology is devoted for applications of nanotechnology to oncology. This journal publishes important original studies in the following areas:

· Basic research on the design and development of nanoparticles for oncology
· Interactions of nanoparticles with cancer cells
· Nanodrug delivery system for prevention and therapy of cancer
· Nanoparticles mediated cancer diagnostic systems
· Nanoparticles for therapy of human cancer
· Clinical trials evaluating nanoceuticals

Designed to objectively cover the world of cardiovascular pharmacology and therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field. Homing in on the most exciting work being done on new therapeutic agents, heart failure, hypertension and acute myocardial infarction, among others, Cardiovascular Drugs and Therapy is an authoritative source of current and relevant news that is indispensable for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Current Contents and Index Medicus, the regular articles and frequent free supplementary issues equip you with an up-to-date source defined by the need for accurate information on an ever-changing field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on extensive reviews and original articles on the treatment of cardiovascular disease. The main focus of the journal is on articles in cardiovascular pharmacology and clinical pharmacology and clinical trials of new or potential cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies and pharmacoepidemiology are also encouraged.

Cardiovascular Toxicology is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on the molecular therapy of cardiovascular disease. CT publishes papers that will elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system. Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs. This is a unique journal in which these data can be scrutinized separately from efficacy.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth, reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Cell Biology and Toxicology is an international journal which publishes papers of high scientific standard in the areas of cell biology, genetic, molecular and cellular toxicology.The journal includes studies of subcellular and cellular systems derived from both prokaryotic and eukaryotic cell types and animal studies.The journal presents scientific reports dealing with the basic biology and with the physiological, pharmacological, and toxic response of cellular systems. Studies of toxic effects may include, but are not limited to, cytotoxicity, mutagenicity, carcinogenicity, and teratogenicity. The major focus of the journal is the mechanisms of action of toxic compounds.Cell Biology and Toxicology publishes papers describing original research results, reviews, announcements of scientific meetings or courses, and availability of funding, fellowships, and scholarships. 

Based in Basel, Switzerland, the multidisciplinary journal Cellular and Molecular Life Sciences (CMLS) publishes research articles, reviews, multi-author reviews and visions & reflections articles covering the latest aspects of biological and biomedical research. The journal will consider contributions focusing on biochemistry and molecular biology, cell biology, molecular and cellular aspects of biomedicine, neuroscience, pharmacology and immunology. In addition, CMLS welcomes comments on any article published in CMLS. Publication Schedule
One volume comprising 24 issues per year Peer Review
Of all contributions by an international board of experts Short Publication Time
Decision on acceptance/rejection within 1 month (for research articles) Online First publication; publication of the print version no more than 2 months after acceptance (for research articles) Illustrations
Black & white, color illustrations at no cost Page Charges
None

Reprints
30 complimentary reprints

Aims and Scope Download Flyer With an impact factor of 3.232 (2009).ChemMedChemon its way to become a premier journal at the interface of chemistry. biology and medicine.ChemMedChemis made in Europe. but publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences. ranging from drug design and discovery to drug development and delivery. from molecular modeling to combinatorial chemistry. from target validation to lead generation and ADMET studies—to name just a few topics. Contents ChemMedChempublishes an attractive mixture of: Short Communications and Full PapersMinireviews and ReviewsHighlights and ConceptsBook and Multimedia ReviewsFields of Interest ChemMedChemtears down the walls between chemistry. biology. and medicine: drug design and discoverydrug development and deliverytarget validationlead generationADMET studiesscreeningbiological activity studiescombinatorial techniquesmolecular modelingsynthesis of biologically active compoundsmetabolism in drug actionsmolecular recognition at receptorsinteraction of ligands and receptorsapplications of NMR and X-ray crystallography ChemMedChemis accepted for coverage in MEDLINE. ISSN: 1860-7179 (print). 1860-7187 (online). CODEN: CHEMGX. Volume 6. 12 Issues in 2011. Masthead Masthead(PDF) –[Show history][Hide history] How to cite:To make sure that references to this journal are correctly recorded and resolved (for example in CrossRef or ISI Web of Science). please use the following abbreviated title in any citations: 'ChemMedChem' (punctuation may vary according to the style of the citing journal).

Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design. The following scientific topics will exemplify the scope of the journal:.

ChemComm publishes urgent research which is of outstanding significance and interest to experts in the field, while also appealing to a broad chemistry readership. Our communication format is ideally suited to short studies that are of such importance that they require accelerated publication. Our scope covers all topics in chemistry, and research at the interface of chemistry and other disciplines (such as materials science, nanoscience, physics, engineering and biology) where there is a significant novelty in the chemistry aspects. Major topic areas covered include Analytical Chemistry, Catalysis, Chemical Biology, Medicinal Chemistry, Computational Chemistry, Machine Learning, Energy and Sustainable Chemistry, Environmental Chemistry, Green Chemistry, Inorganic Chemistry, Materials Chemistry, Nanoscience, Organic Chemistry, Physical Chemistry, Polymer Chemistry and Supramolecular Chemistry.

Chemical Research in Toxicology publishes on a wide range of topics in Toxicology that inform a chemical and molecular understanding and capacity to predict biological outcomes on the basis of structures and processes. The overarching goal of activities reported in the Journal is to provide knowledge and innovative approaches needed to promote intelligent solutions for human safety and ecosystem preservation. The journal emphasizes insight concerning mechanisms of toxicity over phenomenological observations. It upholds rigorous chemical, physical and mathematical standards for characterization and application of modern techniques. Representative research includes:

• Studies concerning the molecular mechanisms by which physical, chemical, or biological agents or materials, interact with and perturb the normal function and/or structure of biological systems, including living organisms, cells, or biomolecules.
• Studies that address hypotheses concerning mechanisms of adverse or therapeutic responses or contribute to the development of models of toxic/biological function on the basis of quantifying chemical, molecular and cellular responses to physical, chemical, or biological agents or materials.
• Studies involving data resulting from high content characterization of molecular responses to agents from the use of bioanalytical approaches such as proteomics, metabolomics, lipidomics, genomics, high content imaging, multi-omics, etc. to characterize targeted patterns or global cellular responses, as well as studies that use novel or existing data to create new models for quantifying exposures or building predictive models of biological pathways or networks.
• The identification and characterization of potentially hazardous agents such as environmental contaminants, industrial chemicals, drugs and drug-like molecules, natural products, biological toxins and engineered nanomaterials, and the development and application of novel methodologies for their detection and/or characterizations of their interactions with biological systems or biomolecules.
• Studies concerning pathological biochemistry and molecular mechanisms of disease etiology involving exogenous as well as endogenous agents and/or molecular pathways or networks.

In the case of uncertainty regarding the suitability of a manuscript, authors may send a pre-submission inquiry to the Editor that includes an abstract and cover letter indicating the intended manuscript format by e-mail (eic@crt.acs.org).

Home to exceptional research and thought-provoking ideas. Open and free, for authors and readers. Chemical Science is the flagship journal of the Royal Society of Chemistry and the home for world-leading, interdisciplinary research from every aspect of the chemical sciences. As a multidisciplinary chemistry journal, our broad scope covers: analytical science and techniques; bioinorganic chemistry; biomaterials; biophysical chemistry; catalysis; chemical biology; chemical engineering; crystal engineering; energy conversion and storage; environmental, sustainable and green chemistry; inorganic chemistry; inorganic materials; main group chemistry; medicinal chemistry; nanoscience; organic chemistry; organic materials; physical chemistry; polymers; porous materials; supramolecular chemistry; and theoretical and computational chemistry.

Chem Soc Rev is the Royal Society of Chemistry's leading reviews journal. We publish high-impact, authoritative and reader-friendly review articles covering important topics at the forefront of the chemical sciences. Reviews should be of the very highest quality and international impact. Our scope covers the breadth of the chemical sciences, including interdisciplinary topics where the article has a basis in chemistry. Topics include Analytical Chemistry, Catalysis, Chemical Biology, Medicinal Chemistry, Computational Chemistry, Machine Learning, Energy and Sustainable Chemistry, Environmental Chemistry, Green Chemistry, Inorganic Chemistry, Materials Chemistry, Nanoscience, Organic Chemistry, Physical Chemistry, Polymer Chemistry and Supramolecular Chemistry.

CBI discourages papers that are descriptive in nature and that do not address toxicological mechanisms (e.g., reports of toxicological effects following chemical exposure in absence of mechanistic experiments). CBI also discourages papers reporting on toxicological effects from materials, such as plant extracts or herbal medicines, that have not been chemically characterized.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservices author services .

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/505510/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com